Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates

This publication has 43 references indexed in Scilit:

• The endocannabinoid system in brain reward processes
  British Journal of Pharmacology, 2008
• Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant
  Neuropsychopharmacology, 2008
• Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
  Nature Neuroscience, 2008
• Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain
  Journal of Lipid Research, 2008
• Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
  Expert Opinion on Investigational Drugs, 2007
• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
  Chemistry & Biology, 2007
• The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
  Neuropharmacology, 2007
• The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
  Current Medical Research and Opinion, 2006
• Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
  Circulation, 2004